A phase II trial comparing pazopanib with doxorubicin as first-line treatment in elderly patients with metastatic or advanced soft tissue sarcoma (EPAZ): study protocol for a randomized controlled trial

DOI: 10.1186/s13063-016-1434-x

Keywords: Soft tissue sarcoma, Elderly, Doxorubicin, Pazopanib, Noninferiority

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text